Medicines and Healthcare products Regulatory Agency (MHRA) opens second round of applications to test cutting-edge AI medical technologies following successful pilot phase.
A £1 million boost to the MHRA pioneering AI Airlock programme will expand access to a first-of-its-kind regulatory testing ground where companies can work directly with regulators to safely test new AI-powered medical devices and explore how to bring them to patients faster, through streamlined regulations.
Applications for the second round of the programme are now open and follow a successful pilot phase that saw four breakthrough AI technologies, including software that could help doctors create personalised cancer treatment plans, and a tool to help hospitals, AI developers, and regulators monitor AI performance in real time, tested in a regulatory ‘sandbox’ environment.
Similar to an airlock on a spacecraft, the ‘sandbox’ testing space creates a boundary between experimental AI and fully approved medical technology used in the real world.
The closing date for applications is 14 July 2025.
For further information and to apply please select the following link: AI Airlock Phase 2 application - GOV.UK